Medications activating tubular fatty acid oxidation enhance the protective effects of roux-en-y gastric bypass surgery in a rat model of early diabetic kidney disease

HIGHLIGHTS

  • who: William P. Martin from the Italy University of La Laguna, Spain have published the article: Medications Activating Tubular Fatty Acid Oxidation Enhance the Protective Effects of Roux-en-Y Gastric Bypass Surgery in a Rat Model of Early Diabetic Kidney Disease, in the Journal: (JOURNAL)
  • what: The authors propose that this design is more translationally relevant to the clinical setting, given that patients with DKD are usually treated with several medications for control of dysglycaemia, dyslipidaemia, hypertension, and dysregulated glomerular haemodynamics . This would switch the line of interrogation to an entirely new model system . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?